Dentsply Sirona (XRAY) shares surged 6.14% in pre-market trading on Thursday following the release of its impressive first-quarter 2025 financial results. The dental equipment and supplies manufacturer significantly outperformed analyst expectations, demonstrating robust growth and operational efficiency.

The company reported adjusted earnings per share (EPS) of $0.43, handily beating the analyst estimate of $0.30. This represents a substantial 43% surprise to the upside. Revenue for the quarter came in at $879 million, surpassing the consensus estimate of $854.75 million and showcasing strong demand for Dentsply Sirona's products and services.

Despite the challenging economic environment, Dentsply Sirona remains confident in its outlook. The company announced that it is maintaining its full-year 2025 guidance for organic sales and adjusted EPS, signaling continued optimism about its business performance. This positive earnings report and sustained outlook have likely contributed to investor enthusiasm, driving the stock's pre-market rally.